Lv6
1940 积分 2022-08-08 加入
2025 年国家基层糖尿病防治管理指南
12天前
已完结
Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
16天前
已完结
Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis
17天前
已完结
Diagnosis and Management of Obstructive Sleep Apnea
24天前
已完结
Comparison of the effectiveness and safety of GLP-1 receptor agonists for type 2 diabetes mellitus patients with overweight/obesity: A systematic review and network meta-analysis
1个月前
已完结
Impact of Semaglutide on Lipid Profiles in Overweight and Obese Non-Diabetic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
1个月前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
1个月前
已完结
肥胖与阻塞性睡眠呼吸暂停综合征的研究进展
1个月前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
1个月前
已完结
Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation
皖公网安备34019202002308
